Today

Agents

Chat

Arena

Discover

More

App

Psyence Biomed Announces Strategic Ibogaine Investment - PBM News | Rallies

Psyence Biomed Announces Strategic Ibogaine Investment

PBM•2026-09-23

Strategic ibogaine investment announced

Psyence Biomedical Ltd PBM.O:

Psyence Biomed announces strategic ibogaine investment
Psyence Biomedical agrees to invest up to $5 million in PsyLabs, with $2.40 million committed
Psyence Biomedical and PsyLabs agree to a $9 million value-matched share exchange
Post-deal, PsyLabs is to hold 49.89% of Psyence Biomed, and Psyence Biomed 41.13% of PsyLabs

Related News

Astrana Health flags material cybersecurity incident after social engineering attack on subsidiary

ASTH•2026-09-23

Lighthouse Canton says AI agent “Muse” hits banks, semis extend Nasdaq highs

SPY•2026-09-23

General Mills Q1 sales, profit beat estimates; reaffirms 2027 outlook

GIS

•

2026-09-23

Morning News Call - U.S., September 23

SPY•2026-09-23

Biomea Fusion Announces Termination Of Proposed Public Offering Of Securities

BMEA•2026-09-23